LQDA
Liquidia Corp
NASDAQ · Healthcare · Biotechnology · US
$66.88
−2.21%Forward multiples
Based on analyst estimates
- P/E forward
- 15.02x
- P/E 2026E
- 21.87x
- P/E 2027E
- 12.05x
- P/E 2028E
- 10.23x
- P/S forward
- 6.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- 42.62x
- PEG TTM
- 0.23x
- Price / book
- 30.68x
- Price / sales
- 13.28x
- Price / cash flow
- 75.75x
Enterprise value
- Enterprise value
- $5.8B
- EV / sales
- 12.93x
- EV / EBITDA
- 32.79x
- EV / EBIT
- 34.59x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026